UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  FORM
10-Q  R QUARTERLY
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  For
the quarterly period ended SEPTEMBER 30, 2008  £ TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934  For
the transition period from ___ to ___  Commission file number:____52649___  BSN
SYSTEMS INC. (Exact
name of registrant as specified in its charter)  _______________Delaware________________
(State or other jurisdiction of incorporation
or organization)
__________20-8408181__________
(I.R.S. Employer Identification No.)18101 Von Karman Ave, Suite 330, Irvine, CA
(Address of principal executive offices)
__92612__
(Zip Code)  Registrants telephone number, including area code:
_949-612-0350_  The registrant (1)
has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act during the preceding 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
    Yes  R   No £  Indicate by check
mark whether the registrant is a large accelerated filer, an accelerated filer,
a non-accelerated filer or a smaller reporting company:  Large
accelerated filer £
Accelerated
filed £Non-accelerated
filer   £
Smaller
reporting company R  Indicate by check
mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act).  Yes R
 No  £  The number of shares
outstanding of the registrants common stock as of November 13, 2008 was
10,000,000 shares with $.0001 par value per share.  1    TABLE
OF CONTENTS  PART
I  FINANCIAL INFORMATION  Item
1.  Financial Statements 3 Balance
Sheets 4 Statements
of Operations 5 Statements
of Cash Flows 6 Notes
to the Financial Statements 7 Item 2.
 Managements Discussion and Analysis of Financial Condition and Results of Operations 10 Item
3.  Quantitative and Qualitative Disclosures About Market Risk 12 Item
4.  Controls and Procedures 12  PART
II  OTHER INFORMATION Item
1.   Legal Proceedings 13 Item
1A Risk Factors 13 Item
2.   Unregistered Sales of Equity Securities and Use of Proceeds 13 Item
3.   Defaults Upon Senior Securities 13 Item
4.  Submission of Matters to a Vote of Security Holders 13 Item
5.  Other Information 13 Item
6.  Exhibits 13 Signatures 14  2   PART I  FINANCIAL INFORMATION  Item 1. Financial
Statements  The
accompanying unaudited financial statements have been prepared in accordance
with generally accepted accounting principles for interim financial reporting
and pursuant to the rules and regulations of the U.S. Securities and Exchange
Commission ("Commission"). While these statements reflect all normal recurring
adjustments which are, in the opinion of management, necessary for fair
presentation of the results of the interim period, they do not include all of
the information and footnotes required by generally accepted accounting
principles for complete financial statements. For further information, refer to
the financial statements and footnotes thereto, contained in the registration
statement filed with the Commission on Form 10-SB.   THESE FINANCIAL STATEMENTS HAVE NOT BEEN REVIEWED BY OUR
INDEPENDENT AUDITORS.  3    BSN
SYSTEMS, INC. (A
DEVELOPMENT STAGE COMPANY) BALANCE SHEET (UNAUDITED)   As of September 30,2008
2007ASSETSCurrent
AssetsCash and cash
equivalents
$
                    -
$
                    -Total
Current Assets
-
-Total
Assets
$
                    -
$
                    -LIABILITIES
AND STOCKHOLDERS EQUITYCurrent
Liabilities
$
 
              120
$
  
             120Total
Liabilities
120
120Stockholders
Equity (Deficit)Preferred stock
- $.0001 par value; 20,000,000 sharesauthorized;
0 shares issued and outstanding
-
-Common stock -
$.0001 par value; 100,000,000 sharesauthorized;
10,000,000 shares issued and outstanding
4,000
3,000Deficit
accumulated during development stage
(4,120)
(3,120)**Total
Stockholders Equity (Deficit)**
(120)
(120)Total
Liabilities and Stockholders Equity
$
                    -
$
                    -   The
accompanying notes are an integral part of these financial statements.   4    BSN
SYSTEMS, INC. (A
DEVELOPMENT STAGE COMPANY) STATEMENTS OF OPERATIONS (UNAUDITED)    For the Three Months Ended September 30,
For the Nine Months Ended September 30,2008
2007
2008
2007RevenuesRevenues
$
             -
$
             -
$
            -
$
           -Total
Revenues
-
-
-
-Operating
Costs and ExpensesGeneral
& Administrative Expenses
-
-
-
-Total
Operating Costs and Expenses
-
-
-
-Net Income
(Loss)
$
             -
$
             -
$
            -
$
           -Basic and
diluted loss per common share
$
             -
$
             -
$
            -
$
           -Basic and
diluted weighted averageCommon
shares outstanding
10,000,000
3,000
10,000,000
3,000   The
accompanying notes are an integral part of these financial statements. *  5   BSN SYSTEMS, INC. (A
DEVELOPMENT STAGE COMPANY) STATEMENTS OF CASH FLOWS (UNAUDITED)    For the Three Months Ended September 30,
For the Nine Months Ended September 30,2008
2007
2008
2007Cash Flows
from Operating ActivitiesNet loss
$     
            -
$
    
              -
$
  
             -
$
               -Issuance of
stock for services rendered
-
-
-
-Net Cash
Provided (Used) by Operating Activities
-
-
-
-Cash Flows from
Investing Activities
-
-
-
-Net Cash Used
in Investing Activities
-
-
-
-Cash Flows from
Financing Activities
-
-
-
-Net Cash
Provided by Financing Activities
-
-
-
-Net Change in
Cash and Cash Equivalents
-
-
-
-Cash and Cash
Equivalents at Beginning of Period
-
-
-
-Cash and Cash
Equivalents at End of Period
$
                 -
$
    
             -
$
   
            -
$
              -Noncash
Financing and Investment ActivitiesCommon
stock issued to founder for services rendered
$
                 -
$
                   -
$
        1,000
$               -Supplemental
Cash Flow InformationInterest
paid
$
      
          -
$
                 -
$
   
           -
$
              -Income
taxes paid
$
     
           -
$
                 -
$
    
          -
$
              -   The
accompanying notes are an integral part of these financial statements.     6   BSN SYSTEMS, INC. (A
DEVELOPMENT STAGE COMPANY) NOTES
TO FINANCIAL STATEMENTS AS OF
SEPTEMBER 30, 2008  NOTE 1 -
DESCRIPTION OF BUSINESS  In this
report references to DKR Holdings, DKR, BSN Systems, BSN, the Company,
we, us, and our refer to BSN Systems, Inc.  Basis of
Presentation  DKR
Holdings, Inc. was incorporated under the laws of the State of Delaware on
October 25, 2006.  On August 14, 2008, we amended of our Certificate of
Incorporation to change our name to BSN Systems, Inc.  BSN has been
inactive since inception and intends to serve as a vehicle to effect an asset
acquisition, merger, exchange of capital stock or other business combination
with a domestic or foreign business.  BSN has
not earned any revenue from operations.  Accordingly, BSN's activities have
been accounted for as those of a Development Stage Enterprise" as set forth in
Financial Accounting Standards Board Statement No. 7 ("SFAS 7").  BSN's
financial statements are identified as those of a development stage company, and
that the statements of operations, stockholders' equity and cash flows disclose
activity since the date of BSN's inception.  NOTE 2 - SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES  Accounting
Method  BSN's
financial statements are prepared using the accrual method of accounting. BSN
has elected a fiscal year ending on December 31.  Use of
Estimates  The
preparation of financial statements in conformity with generally accepted
accounting  principles  requires  management to make estimates
and  assumptions that affect the reported amounts of  assets  and
 liabilities, disclosure of contingent assets and liabilities at the date
of the  financial  statements and the reported amounts of revenues and
expenses during the reporting  period.  Actual results could differ
from those estimates.  Cash
Equivalents  BSN
considers all highly liquid investments with maturity of three months or less
when purchased to be cash equivalents.  7    Income
Taxes  Income
taxes are provided in accordance with Statement of Financial Accounting
Standards No. 109 (SFAS 109), Accounting for Income Taxes.  A deferred tax
asset or liability is recorded for all temporary differences between financial
and tax reporting and net operating loss carry forwards.  Deferred tax
expense (benefit) results from the net change during the year of deferred tax
assets and liabilities. Deferred tax assets are reduced by a valuation allowance
when, in the opinion of management, it is more likely than not that some portion
of all of the deferred tax assets will be realized.  Deferred tax assets
and liabilities are adjusted for the effects of changes in tax laws and rates on
the date of enactment. There were no current or deferred income tax expenses or
benefits due to BSN not having any material operations for period ended
September 30, 2008.  Earnings per
Share  BSN
adopted the provisions of SFAS No. 128, "Earnings Per Share" ("EPS").  SFAS
No. 128 provides for the calculation of basic and diluted earnings per share.
  Basic EPS includes no dilution and is computed by dividing income or
loss available to common stockholders by the weighted average number of common
shares outstanding for the period.  Diluted EPS reflects the potential
dilution of securities that could share in the earnings or losses of the entity.
 Such amounts include shares potentially issuable pursuant to shares to be
issued, convertible debentures and outstanding options and warrants.  Impact of New
Accounting Standards  BSN
 does  not  expect  the  adoption  of recently
 issued  accounting pronouncements  to  have  a
 material  impact on the  BSN's  results  of
operations, financial position, or cash flow.  NOTE 3 - GOING
CONCERN  BSN's
consolidated financial statements are prepared using the accrual method of
accounting in accordance with accounting principles generally accepted in the
United States of America ("GAAP"), and have been prepared on a going concern
basis, which contemplates the realization of assets and the settlement of
liabilities in the normal course of business.  BSN currently has no source
of revenue to cover its costs.  BSN will limit all operational activities
to searching and consummating a business combination.  BSN will offer
non-cash consideration and seek equity lines as the sole method of financing for
the near term.  If BSN is unable to secure financing until a business
combination is consummated, it may substantially limit or terminate its
operations or seek other business opportunities through strategic alliances,
acquisitions or other arrangements that may dilute the interests of existing
stockholders.  NOTE 4 -
SHAREHOLDER'S EQUITY   On
October 25, 2006 (inception), BSN issued 3,000 shares of BSNs Common stock
value at $3,000 for services to founder, sole officer and director, Huong Tran.
 Ms. Tran, the sole officer and director, is the sole shareholder of the
BSN. With respect to the share issuance to Ms. Tran, BSN relied upon Section
4(2) of the Securities Act of 1933, as amended (the "Securities Act") and Rule
506 promulgated thereunder. Such security holder cannot rely on Rule 144 for
resale transactions and therefore can only be resold through Registration under
the Securities Act.  8       On
September 30, 2008, per the Shares Purchase Agreement, Ms. Tran assigned 3,000
shares of BSNs Common stock to Kesef Worldwide Investments LLC, formerly
American Fries of Utah, LLC.  In addition, BSN issued 9,997,000 shares
of BSNs Common stock value at $1,000 for services to Kesef Worldwide
Investments.  Kesef Worldwide Investments is the sole shareholder of the
BSN. With respect to the share issuance to Kesef Worldwide Investments, BSN
relied upon Section 4(2) of the Securities Act of 1933, as amended (the
"Securities Act") and Rule 506 promulgated thereunder. Such security holder
cannot rely on Rule 144 for resale transactions and therefore can only be resold
through Registration under the Securities Act.  BSN has
the following classes of capital stock as of November 13, 2008:  Common
stock  100,000,000 shares authorized; $0.0001 par value; 10,000,000 shares
issued and outstanding.  Preferred stock  20,000,000 shares authorized; $0.0001 par value;
no shares issued and outstanding.   9    Item 2.
  Managements Discussion and Analysis of Financial Condition and
Results of Operations  FORWARD LOOKING
STATEMENTS  The
Securities and Exchange Commission (SEC) encourages companies to disclose
forward-looking information so that investors can better understand future
prospects and make informed investment decisions.  This report contains
these types of statements.  Words such as may, will, intend,
 expect, believe, anticipate, estimate, project, or continue or
comparable terminology used in connection with any discussion of future
operating results or financial performance identify forward-looking statements.
 You are cautioned not to place undue reliance on the forward-looking
statements, which speak only as of the date of this report.  All
forward-looking statements reflect our present expectation of future events and
are subject to a number of important factors and uncertainties that could cause
actual results to differ materially from those described in the forward-looking
statements.  The
following discussion and analysis should be read in conjunction with our
financial statements and notes to the financial statements included elsewhere in
this report as well as the 10-KSB annual report.  This report contains
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933, as amended, or the Securities Act, and Section 21E of the
Securities Exchange Act of 1934, as amended, or the Exchange Act.  We
intend that the forward-looking statements be subject to the safe harbors
created by those sections.  COMPANY OVERVIEW  We were
organized on October 25, 2006, as a blank check or shell company under the Laws
of the State of Delaware.  We do not currently engage in any business
activities that provide cash flow.  From inception, our primary activity
has been directed towards organizational efforts, compliance matters and
locating potential merger or acquisition candidates.  Our primary purpose
is to engage in a merger with or acquisition of one or more private domestic or
foreign companies.  On
August 14, 2008, we amended of our Certificate of Incorporation to change our
name to BSN Systems, Inc.  BUSINESS
COMBINATION  Our
main objective is to achieve long-term growth potential through a combination
with a business.  We will not restrict the potential candidate target
companies to any specific business, industry or geographical location and, thus,
may acquire any type of business.  At present, we have no business
opportunities under contemplation for acquisitions.  No assurances can be
given that we will be successful in locating or negotiating with any target
business.  We may
consider a business which has recently commenced operations, is a developing
company in need of working capital, is seeking to develop a new product or
service, or is an established business which may be experiencing financial or
operating difficulties and is in need of additional capital.
 Alternatively, a business combination may involve the acquisition of, or
merger with, a company which does not need substantial financing, but which
desires to establish a public trading market for its shares.  10    Any
selected target business may be a financially unstable company or an entity in
its early stages of development or growth, including entities without
established records of sales or earnings. In that event, we will be subject to
numerous risks inherent in the business and operations of financially unstable
and early stage or potential emerging growth companies. In addition, we may
effect a business combination with an entity in an industry characterized by a
high level of risk, and, although management will endeavor to evaluate the risks
inherent in a particular target business, there can be no assurance that
management will properly ascertain or assess all significant risks.  The
business combination will most likely take the form of a non-cash merger, stock
swap or stock-for-assets exchange.  It is anticipated that any securities
issued in any such business combination would be issued in reliance upon
exemption from registration under applicable federal and state securities laws.
 As may dictate by the transaction, the surviving company may register all
or a part of such securities immediately after the transaction is consummated or
at specified times thereafter.  RESULTS
OF OPERATION  Net
Revenue  The net
revenues for the three months ended September 30, 2008 was $0 as compared to net
revenues of $0 for the three months ended September 30, 2007.  The net
revenues for the nine months ended September 30, 2008 was $0 as compared to net
revenues of $0 for the nine months ended September 30, 2007.  Operating Expenses  The
operating expenses for the three months ended September 30, 2008 was $0 as
compared to operating expenses of $0 for the three months ended September 30,
2007.  The
operating expenses for the nine months ended September 30, 2008 was $0 as
compared to operating expenses of $0 for the nine months ended September 30,
2007.  Net
Income  As a
result of the above, the net income for the three months ended September 30,
2008 was $0.  The basic and diluted income per share was $0 during the
three months ended September 30, 2008.  The net
income for the nine months ended September 30, 2008 was $0.  The basic and
diluted income per share was $0 during the nine months ended September 30,
2008.  Liquidity and Capital Resources  As of
September 30, 2008, we have $0 in cash and assets and $120 in current
liabilities.  Cash
Flows from Operating Activities  We do
not currently engage in any business activities that provide cash flow.
 The costs of investigating and analyzing business combinations will be
financed by our stockholders, management or other investors.   11    Item 3.
Quantitative and Qualitative Disclosures About Market Risk  Not applicable.   Item 4. Controls
and Procedures  Disclosure
Controls and Procedures  We
maintain disclosure controls and procedures that are designed to ensure that
information required to be disclosed in our filings under the Exchange Act is
recorded, processed, summarized and reported within the periods specified in the
rules and forms of the SEC.  This information is accumulated to allow
timely decisions regarding required disclosure.  Our Chief Executive Officer and principal financial
officer, evaluated the effectiveness of our disclosure controls and procedures
as of the end of the period covered by this report.  Based on that
evaluation, our CEO concluded that our disclosure controls and procedures were
effective.  Managements
Report on Internal Control over Financial Reporting  Our CEO
is responsible to design or supervise a process to be effected by our board of
directors that provides reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles.  The
policies and procedures include:  · maintenance of records in reasonable detail to accurately and
fairly reflect the transactions and dispositions of  assets, · reasonable assurance that transactions are recorded as necessary
to permit preparation of financial statements in accordance with generally
accepted accounting principles, and that receipts and expenditures are being
made only in accordance with authorizations of management and directors, and · reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use or disposition of assets that could have a
material effect on our financial statements.  Our
management determined that there were no changes made in our internal controls
over financial reporting during the first quarter of 2008 that have materially
affected, or are reasonably likely to materially affect our internal control
over financial reporting.   12    PART
II  OTHER INFORMATION  Item 1.
 Legal Proceedings  None.  Item 1A.
 Risk Factors  Not applicable.  Item 2.
 Unregistered Sales of Equity Securities and Use of Proceeds  None.  Item 3.
 Defaults Upon Senior Securities  None.  Item 4.
 Submission of Matters to a Vote of Security Holders  None.  Item 5.
 Other Information  None.  Item 6.
 Exhibits  Exhibit Number,
Name and/or Identification of Exhibit  31
Certification of the Chief Executive Officer and Chief
Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of
200232
Certification of the Chief Executive Officer and Chief
Financial Officer pursuant to U.S.C. Section 1350 as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002   13   SIGNATURES  Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly
authorized.   BSN Systems,
Inc. (Registrant)  Date: November 13,
2008   By: /s/ Gerald
Bush Gerald Bush Title: Chief
Executive Officer, Chief Financial Officer and
Director   14